Dong Fei, Zhao Cheng, Lei Ling, Zheng Leting, Wen Jing, Qin Fang
Department of Rheumatology and Immunology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Lupus. 2024 Oct;33(12):1389-1398. doi: 10.1177/09612033241283547. Epub 2024 Sep 12.
To summarize the causes of death and clinical characteristics of systemic lupus erythematosus (SLE) hospitalized patients in the last 20 years to improve SLE survival rates by detecting critical SLE early.
In this case-control study, 218 SLE death cases were retrospectively analyzed from January 2002 to December 2022, with 110 SLE inpatients chosen at random as controls. The clinical symptoms, causes of death, and risk factors in patients with SLE were investigated.
There were 218 deaths among 9538 patients with SLE, including 188 women and 30 men. The death rate fell steadily from 4.14% in 2002 to 1.96% in 2013 and remained at 1.84% from 2014 to 2022. The standardized mortality ratio (SMR) was 4.98 [95% CI (4.06-5.89)] from 2002 to 2012 and 3.39 [95% CI (2.74-4.04)] from 2013 to 2022. Infection, lupus-induced multiple organ failure syndrome (MODS), and neuropsychiatric lupus (NPLE) were the leading causes of death, accounting for 31.19%, 15.14%, and 11.47% of overall deaths. Age had a significant association with the major causes of death. Logistic regression analysis showed NPLE[OR = 10.772,95% CI (3.350,34.633), < 0.001], lupus pulmonary involvement (LP)[OR = 3.844,95%CI (1.547,9.552), = 0.004], pneumonia[OR = 3.439,95%CI(1.552,7.621), = 0.002], thrombocytopenia[OR = 14.941,95%CI (4.088,54.604), < 0.001], creatinine>177 μmol/L[OR = 8.644,95%CI (2.831,26.388), < 0.001], glutamic transaminase(AST) > 60U/L[OR = 5.762,95%CI (2.200,15.088), < 0.001], total bilirubin > 34 μmol/L[OR = 16.701,95%CI (3.349,83.294), = 0.001], higher SLE Disease Activity Index (SLEDAI)[OR = 1.089,95%CI (1.032,1.149), = 0.002] and SLE Damage Index (SDI)[OR = 3.690,95%CI (2.487,5.474), < 0.001] correlated positively with death.
From 2002 to 2013, the mortality rate among patients with SLE fell steadily but remained unchanged from 2014 to 2022. Patients with SLE had significantly higher SMR than the general population. Childhood-onset SLE had a poorer prognosis than adult-onset SLE. Infection, MODS, and NPLE were the three leading causes of death. Major organ involvement and high disease activity were risk factors for mortality.
总结过去20年系统性红斑狼疮(SLE)住院患者的死亡原因及临床特征,通过早期发现SLE关键问题提高其生存率。
在这项病例对照研究中,回顾性分析了2002年1月至2022年12月期间218例SLE死亡病例,并随机选取110例SLE住院患者作为对照。调查SLE患者的临床症状、死亡原因及危险因素。
9538例SLE患者中有218例死亡,其中女性188例,男性30例。死亡率从2002年的4.14%稳步下降至2013年的1.96%,2014年至2022年维持在1.84%。2002年至2012年标准化死亡比(SMR)为4.98 [95%可信区间(4.06 - 5.89)],2013年至2022年为3.39 [95%可信区间(2.74 - 4.04)]。感染、狼疮所致多器官功能衰竭综合征(MODS)和神经精神性狼疮(NPLE)是主要死亡原因,分别占总死亡人数的31.19%、15.14%和11.47%。年龄与主要死亡原因显著相关。Logistic回归分析显示,NPLE[比值比(OR) = 10.772,95%可信区间(3.350,34.633),P < 0.001]、狼疮肺部受累(LP)[OR = 3.844,95%可信区间(1.547,9.552),P = 0.004]、肺炎[OR = 3.439,95%可信区间(1.552,7.621),P = 0.002]、血小板减少[OR = 14.941,95%可信区间(4.088,54.604),P < 0.001]、肌酐>177 μmol/L[OR = 8.644,95%可信区间(2.831,26.388),P < 0.001]、谷氨酸转氨酶(AST)> 60 U/L[OR = 5.762,95%可信区间(2.200,15.088),P < 0.001]、总胆红素> 34 μmol/L[OR = 16.701,95%可信区间(3.349,83.294),P = 0.001]、较高的SLE疾病活动指数(SLEDAI)[OR = 1.089,95%可信区间(1.032,1.149),P = 0.002]和SLE损伤指数(SDI)[OR = 3.690,95%可信区间(2.487,5.474),P < 0.001]与死亡呈正相关。
2002年至2013年,SLE患者死亡率稳步下降,但2014年至2022年保持不变。SLE患者的SMR显著高于一般人群。儿童期发病的SLE预后比成人期发病的SLE差。感染、MODS和NPLE是三大主要死亡原因。主要器官受累和高疾病活动度是死亡的危险因素。